SI1007040T1 - Use of phanquinone for the treatment of alzheimer's disease - Google Patents

Use of phanquinone for the treatment of alzheimer's disease

Info

Publication number
SI1007040T1
SI1007040T1 SI9830223T SI9830223T SI1007040T1 SI 1007040 T1 SI1007040 T1 SI 1007040T1 SI 9830223 T SI9830223 T SI 9830223T SI 9830223 T SI9830223 T SI 9830223T SI 1007040 T1 SI1007040 T1 SI 1007040T1
Authority
SI
Slovenia
Prior art keywords
phanquinone
alzheimer
disease
treatment
Prior art date
Application number
SI9830223T
Other languages
Slovenian (sl)
Inventor
Michel Xilinas
Panayotis Nikolas Gerolymatos
Original Assignee
P.N. Gerolymatos S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by P.N. Gerolymatos S.A. filed Critical P.N. Gerolymatos S.A.
Priority claimed from PCT/IB1998/001095 external-priority patent/WO1999009981A1/en
Publication of SI1007040T1 publication Critical patent/SI1007040T1/en

Links

SI9830223T 1997-08-21 1998-07-17 Use of phanquinone for the treatment of alzheimer's disease SI1007040T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GR97100330 1997-08-21
GR97100507 1997-12-31
PCT/IB1998/001095 WO1999009981A1 (en) 1997-08-21 1998-07-17 Use of phanquinone for the treatment of alzheimer's disease
EP98930970A EP1007040B1 (en) 1997-08-21 1998-07-17 Use of phanquinone for the treatment of alzheimer's disease

Publications (1)

Publication Number Publication Date
SI1007040T1 true SI1007040T1 (en) 2002-10-31

Family

ID=27239844

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830223T SI1007040T1 (en) 1997-08-21 1998-07-17 Use of phanquinone for the treatment of alzheimer's disease

Country Status (1)

Country Link
SI (1) SI1007040T1 (en)

Similar Documents

Publication Publication Date Title
EP1043991A4 (en) Treatment for alzheimer's disease
EP1007048A4 (en) Identification of agents for use in the treatment of alzheimer's disease
HUP0103654A2 (en) Use of smilagenin and anzurogenin-d for production of pharmaceutical compositions for the treatment of alzheimer's disease
EP0735870A4 (en) Use of pla 2? inhibitors as treatment for alzheimer's disease
HUP0003852A3 (en) Use of highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
AP2001002102A0 (en) Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas
HUP0002030A3 (en) Use of glur5 receptorantagonists for the treatment of pain
IL127146A0 (en) Transdermal propentofylline compositions for the treatment of alzheimer's disease
ZA989365B (en) Preparation for treating alzheimer's disease
IL119417A0 (en) Drug for Parkinson's disease
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
IL121730A0 (en) Process for the preparation of 2'-fluoro-5-methyl-beta-L-arabino-furanosyluridine
HUP0004331A3 (en) Use of phanquinone for producing pharmaceutical compositions for the treatment of alzheimer's disease and combined pharmaceutical compositions containing it
IL117695A0 (en) Pharmaceutical agents for the treatment of alzheimer's disease
GB0011410D0 (en) Therapeutic combination for treating Alzheimer's disease
AU1405899A (en) Treatment for alzheimer's disease
GB0011408D0 (en) Therapeutic combination for treating Alzheimer's Disease
EP1181550A4 (en) Methods for the identification of compounds for the treatment of alzheimer's disease
EP0981357A4 (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
EP0755262A4 (en) Composition for the treatment of lung disease
HUP0103149A3 (en) Pharmaceutical composition for treatment of alzheimer's disease
SI1007040T1 (en) Use of phanquinone for the treatment of alzheimer's disease
HUP0000569A3 (en) Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
EP0979234A4 (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
GB9709416D0 (en) Methods for treatment of alzheimer's disease using azaspiranes